|
Feb 5
|
Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
|
|
Dec 11
|
Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD
|
|
Nov 30
|
Orchard Therapeutics Receives U.S. FDA Fast Track Designation for OTL-203 in MPS-IH
|
|
Aug 31
|
Orchard Therapeutics Announces Presentation of Data Comprising the Clinical Package for the OTL-200 BLA in MLD at the SSIEM Annual Symposium 2023
|